AN2 Therapeutics (ANTX) Shares Outstanding (Diluted) (2021 - 2026)

AN2 Therapeutics (ANTX) Shares Outstanding (Diluted) (2021 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Dil.) (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 255.20 Mn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 106.00 Mn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 64.41 Mn
4 Revolution Medicines 43.64 Bn 43.64 Bn - 210.89 Mn
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 1.51 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 25.05 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn - 556.90 Mn
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 138.28 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 217.35 Mn
10 AN2 Therapeutics 226.04 Mn 226.04 Mn - 44.76 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 44.76 Mn
Mar 31, 2026 34.06 Mn
Dec 31, 2025 30.22 Mn
Sep 30, 2025 30.28 Mn
Jun 30, 2025 30.17 Mn
Mar 31, 2025 30.05 Mn
Dec 31, 2024 29.83 Mn
Sep 30, 2024 29.84 Mn
Jun 30, 2024 29.82 Mn
Mar 31, 2024 29.76 Mn
Dec 31, 2023 23.60 Mn
Sep 30, 2023 25.65 Mn
Jun 30, 2023 19.50 Mn
Mar 31, 2023 19.39 Mn
Dec 31, 2022 15.34 Mn
Sep 30, 2022 19.35 Mn
Jun 30, 2022 19.26 Mn
Mar 31, 2022 3.18 Mn
Dec 31, 2021 2.64 Mn
Sep 30, 2021 2.64 Mn